Skip to main content
SpringerLink
Log in

Pathology of Clear Cell Tumors

  • Chapter
  • First Online:
Book cover Diagnostic Pathology of Ovarian Tumors

  • 1777 Accesses

Abstract

This chapter discusses the pathology of clear cell tumors: macroscopic and microscopic features, immunophenotype, molecular biology, and treatment and clinical outcomes. Clear cell carcinoma precursors are discussed (endometriosis, clear cell adenofibroma), as are differential diagnoses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Seidman JD, Horkayne-Szakaly I, Haiba M, Boice CR, Kurman RJ, Ronnett BM. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol. 2004;23(1):41–4.

    Article  PubMed  Google Scholar 

  2. Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer. 2000;88(11):2584–9.

    Article  PubMed  CAS  Google Scholar 

  3. Leitao Jr MM, Boyd J, Hummer A, et al. Clinicopathologic analysis of early-stage sporadic ovarian carcinoma. Am J Surg Pathol. 2004;28(2):147–59.

    Article  PubMed  Google Scholar 

  4. Mizuno M, Kikkawa F, Shibata K, et al. Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary. J Surg Oncol. 2006;94(2):138–43.

    Article  PubMed  Google Scholar 

  5. Takano M, Kikuchi Y, Yaegashi N, et al. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer. 2006;94(10):1369–74.

    Article  PubMed  CAS  Google Scholar 

  6. Behbakht K, Randall TC, Benjamin I, Morgan MA, King S, Rubin SC. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol. 1998;70:255–8.

    Article  PubMed  CAS  Google Scholar 

  7. Han G, Gilks CB, Leung S, et al. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases. Am J Surg Pathol. 2008;32(7):955–64.

    Article  PubMed  Google Scholar 

  8. Gilks CB, Ionescu DN, Kalloger SE, et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum Pathol. 2008;39(8):1239–51.

    Article  PubMed  CAS  Google Scholar 

  9. Garg K, Leitao Jr MM, Kauff ND, et al. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Am J Surg Pathol. 2009;33(6):925–33.

    Article  PubMed  Google Scholar 

  10. Jensen KC, Mariappan MR, Putcha GV, et al. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Am J Surg Pathol. 2008;32(7):1029–37.

    Article  PubMed  Google Scholar 

  11. DeLair D, Soslow R, Gilks B, Macias A, Oliva E. The morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 83 cases. Mod Pathol. 2009;22 Suppl 1:211A. abstract 961.

    Google Scholar 

  12. Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology. 1997;30(3):249–55.

    Article  PubMed  CAS  Google Scholar 

  13. Moll UM, Chumas JC, Chalas E, Mann WJ. Ovarian carcinoma arising in atypical endometriosis. Obstet Gynecol. 1990;75:537–9.

    PubMed  CAS  Google Scholar 

  14. Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol. 2009;14(5):383–91.

    Article  PubMed  Google Scholar 

  15. Kobayashi H. Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis. Int J Clin Oncol. 2009;14(5):378–82.

    Article  PubMed  Google Scholar 

  16. LaGrenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis. Hum Pathol. 1988;19:1080–4.

    Article  PubMed  CAS  Google Scholar 

  17. Brescia RJ, Dubin N, Demopoulos RI. Endometrioid and clear cell carcinoma of the ovary. Factors affecting survival. Int J Gynecol Pathol. 1989;8:132–8.

    Article  PubMed  CAS  Google Scholar 

  18. Czernobilsky B, Silverman BB, Enterline HT. Clear cell carcinoma of the ovary. A clinicopathologic analysis of pure and mixed forms and comparison with endometrioid carcinoma. Cancer. 1970;25:762–72.

    Article  PubMed  CAS  Google Scholar 

  19. Asad H, Soslow RA. Clinicopathologic and immunohistochemical analysis of mixed epithelial ovarian tumors with a clear cell carcinoma component. Mod Pathol. 2008;21 Suppl 1:195A. abstract 894.

    Google Scholar 

  20. Czernobilsky B, Morris WJ. A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. Obstet Gynecol. 1979;53:318–23.

    PubMed  CAS  Google Scholar 

  21. Seidman JD. Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol. 1996;15(1):1–9.

    Article  PubMed  CAS  Google Scholar 

  22. Ballouk F, Ross JS, Wolf BC. Ovarian endometriotic cysts analysis cytologic atypia DNA ploidy patterns. Am J Clin Pathol. 1994;102:415–9.

    PubMed  CAS  Google Scholar 

  23. Yamamoto S, Tsuda H, Yoshikawa T, et al. Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics. Am J Surg Pathol. 2007;31(7):999–1006.

    Article  PubMed  Google Scholar 

  24. Yamamoto S, Tsuda H, Takano M, et al. Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors. Mod Pathol. 2008;21(2):115–24.

    PubMed  CAS  Google Scholar 

  25. Veras E, Mao TL, Ayhan A, et al. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol. 2009;33(6):844–53.

    Article  PubMed  Google Scholar 

  26. Bell DA, Scully RE. Benign and borderline clear cell adenofibromas of the ovary. Cancer. 1985;56:2922–31.

    Article  PubMed  CAS  Google Scholar 

  27. Roth LM, Langley FA, Fox H, Wheeler JE, Czernobilsky B. Ovarian clear cell adenofibromatous tumors: benign, low malignant potential, and associated with invasive clear cell carcinoma. Cancer. 1984;53:1156–63.

    Article  PubMed  CAS  Google Scholar 

  28. Kobel M, Kalloger SE, Carrick J, et al. A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. Am J Surg Pathol. 2009;33(1):14–21.

    Article  PubMed  Google Scholar 

  29. Lee S, Garner EI, Welch WR, Berkowitz RS, Mok SC. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecol Oncol. 2007;106(2):311–7.

    Article  PubMed  CAS  Google Scholar 

  30. Lin F, Zhang PL, Yang XJ, et al. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol. 2007;31(3):371–81.

    Article  PubMed  Google Scholar 

  31. Stadlmann S, Gueth U, Baumhoer D, Moch H, Terracciano L, Singer G. Glypican-3 expression in primary and recurrent ovarian carcinomas. Int J Gynecol Pathol. 2007;26(3):341–4.

    Article  PubMed  Google Scholar 

  32. Yamamoto S, Tsuda H, Aida S, Shimazaki H, Tamai S, Matsubara O. Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium. Hum Pathol. 2007;38(7):1074–80.

    Article  PubMed  CAS  Google Scholar 

  33. Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol. 2006;19(1):83–9.

    Article  PubMed  CAS  Google Scholar 

  34. Tsuchiya A, Sakamoto M, Yasuda J, et al. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol. 2003;163(6):2503–12.

    Article  PubMed  CAS  Google Scholar 

  35. Amemiya S, Sekizawa A, Otsuka J, Tachikawa T, Saito H, Okai T. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability. Int J Gynaecol Obstet. 2004;86(3):371–6.

    Article  PubMed  CAS  Google Scholar 

  36. Sato N, Tsunoda H, Nishida M, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 2000;60(24):7052–6.

    PubMed  CAS  Google Scholar 

  37. Cai KQ, Albarracin C, Rosen D, et al. Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Hum Pathol. 2004;35(5):552–9.

    Article  PubMed  CAS  Google Scholar 

  38. Gras E, Catasus L, Argueelles R, et al. Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer. 2001;92(11):2829–36.

    Article  PubMed  CAS  Google Scholar 

  39. Kuo KT, Mao TL, Jones S, et al. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol. 2009;174(5):1597–601.

    Article  PubMed  CAS  Google Scholar 

  40. Garg K, Shih K, Barakat RR, Zhou Q, Iasonos A, Soslow RA. Endometrial carcinomas in women age 40 years and younger: tumors associated with loss of DNA mismatch repair proteins appear to be a distinct clinicopathologic subset 2009. Am J Surg Pathol. 2009;33(2):1869–77.

    Article  PubMed  Google Scholar 

  41. Wiegand KC, Shah SP, Al-Agha OM, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363:1532–43.

    Article  PubMed  CAS  Google Scholar 

  42. Sangoi AR, Soslow RA, Teng NN, Longacre TA. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential. Am J Surg Pathol. 2008;32(2):269–74.

    Article  PubMed  Google Scholar 

  43. Silva EG, Young RH. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type. Am J Surg Pathol. 2007;31(8):1203–8.

    Article  PubMed  Google Scholar 

  44. Esheba GE, Pate LL, Longacre TA. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Am J Surg Pathol. 2008;32(4):600–7.

    Article  PubMed  Google Scholar 

  45. Cao D, Guo S, Allan RW, Molberg KH, Peng Y. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009;33(6):894–904.

    Article  PubMed  Google Scholar 

  46. Ramalingam P, Malpica A, Silva EG, Gershenson DM, Liu JL, Deavers MT. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004;28(11):1499–505.

    Article  PubMed  Google Scholar 

  47. Gordon A, Lipton D, Woodruff JD. Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynecol. 1981;58:497–504.

    PubMed  CAS  Google Scholar 

  48. Zaloudek CJ, Tavassoli FA, Norris HJ. Dysgerminoma with syncytiotrophoblastic giant cells: a histologically and clinically distinctive subtype of dysgerminoma. Am J Surg Pathol. 1981;5:361–7.

    Article  PubMed  CAS  Google Scholar 

  49. Lifschitz-Mercer B, Walt H, Kushnir I, et al. Differentiation potential of ovarian dysgerminoma: an immunohistochemical study of 15 cases. Hum Pathol. 1995;26:62–6.

    Article  PubMed  CAS  Google Scholar 

  50. Cheng L, Thomas A, Roth LM, Zheng W, Michael H, Karim FW. OCT4: a novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol. 2004;28(10):1341–6.

    Article  PubMed  Google Scholar 

  51. Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 case. Am J Surg Pathol. 1984;8:575–96.

    Article  PubMed  CAS  Google Scholar 

  52. Irving JA, Young RH. Granulosa cell tumors of the ovary with a pseudopapillary pattern: a study of 14 cases of an unusual morphologic variant emphasizing their distinction from transitional cell neoplasms and other papillary ovarian tumors. Am J Surg Pathol. 2008;32(4):581–6.

    Article  PubMed  Google Scholar 

  53. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms – An immunohistochemical study of 215 cases. Am J Surg Pathol. 2002;26(11):1477–83.

    Article  PubMed  Google Scholar 

  54. Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol. 2003;16(6):584–90.

    Article  PubMed  Google Scholar 

  55. Gaffey MJ, Mills SE, Boyd JC. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma: manifestations of von Hippel-Lindau disease. Am J Surg Pathol. 1994;18:1254–60.

    Article  PubMed  CAS  Google Scholar 

  56. Aydin H, Young RH, Ronnett BM, Epstein JI. Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell Carcinoma. Am J Surg Pathol. 2005;29(4):520–3.

    Article  PubMed  Google Scholar 

  57. Gersell DJ, King TC. Papillary cystadenoma of the mesosalpinx in von Hippel-Lindau disease. Am J Surg Pathol. 1988;12:145–9.

    Article  PubMed  CAS  Google Scholar 

  58. Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol. 2006;30(3):277–99.

    PubMed  Google Scholar 

  59. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol. 2003;27(7):985–93.

    Article  PubMed  Google Scholar 

  60. Khunamornpong S, Suprasert P, Chiangmai WN, Siriaunkgul S. Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand. Int J Gynecol Cancer. 2006;16 Suppl 1:132–8.

    Article  PubMed  Google Scholar 

  61. Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27(3):281–92.

    Article  PubMed  Google Scholar 

  62. Kobel M, Xu H, Bourne PA, et al. IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype. Mod Pathol. 2009;22(3):469–75.

    Article  PubMed  Google Scholar 

  63. Kobel M, Kalloger SE, Santos JL, Huntsman DG, Gilks CB, Swenerton KD. Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications. Gynecol Oncol. 2010;116(1):50–6.

    Article  PubMed  Google Scholar 

  64. Itamochi H, Kigawa J, Terakawa N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 2008;99(4):653–8.

    Article  PubMed  CAS  Google Scholar 

  65. Eltabbakh GH, Mount SL, Beatty B, Simmons-Arnold L, Cooper K. Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma. J Surg Oncol. 2006;93(5):379–86.

    Article  PubMed  CAS  Google Scholar 

  66. Nagai Y, Inamine M, Hirakawa M, et al. Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary. Gynecol Oncol. 2007;107(3):469–73.

    Article  PubMed  Google Scholar 

  67. Ishikura H, Scully RE. Hepatoid carcinoma of the ovary newly described tumor. Cancer. 1987;60:2775–84.

    Article  PubMed  CAS  Google Scholar 

  68. Matsuta M, Ishikura H, Murakami K, Kagabu T, Nishiya I. Hepatoid carcinoma of the ovary: a case report. Int J Gynecol Pathol. 1991;10(3):302–10.

    Article  PubMed  CAS  Google Scholar 

  69. Prat J, Bhan AK, Dickersin GR, Robboy SJ, Scully RE. Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation): a light microscopic, ultrastructural and immunohistochemical study of seven cases. Cancer. 1982;50:2355–68.

    Article  PubMed  CAS  Google Scholar 

  70. Young RH, Gersell DJ, Clement PB, Scully RE. Hepatocellular carcinoma metastatic to the ovary: a report of three cases discovered during life with discussion of the differential diagnosis of hepatoid tumors of the ovary. Hum Pathol. 1992;23:574–80.

    Article  PubMed  CAS  Google Scholar 

  71. Hayes MC, Scully RE. Ovarian steroid cell tumors (not otherwise specified). A clinicopathological analysis of 63 cases. Am J Surg Pathol. 1987;11:835–45.

    Article  PubMed  CAS  Google Scholar 

  72. Kurman RJ, Norris HJ. Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear cell leiomyoma: a clinical and pathological analysis of 26 cases. Cancer. 1976;37:1853–65.

    Article  PubMed  CAS  Google Scholar 

  73. Vang R, Kempson RL. Perivascular epithelioid cell tumor (‘PEComa’) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol. 2002;26(1):1–13.

    Article  PubMed  Google Scholar 

  74. Altrabulsi B, Malpica A, Deavers MT, Bodurka DC, Broaddus R, Silva EG. Undifferentiated carcinoma of the endometrium. Am J Surg Pathol. 2005;29(10):1316–21.

    Article  PubMed  Google Scholar 

  75. Irving JA, Lerwill MF, Young RH. Gastrointestinal stromal tumors metastatic to the ovary: a report of five cases. Am J Surg Pathol. 2005;29(7):920–6.

    Article  PubMed  Google Scholar 

  76. Shih IM, Kurman RJ. Epithelioid trophoblastic tumor – A neoplasm distinct from choriocarcinoma and placental site tropho­blastic tumor simulating carcinoma. Am J Surg Pathol. 1998;22:1393–403.

    Article  PubMed  CAS  Google Scholar 

  77. Soslow R. Histologic Subtypes of ovarian carcinoma: an overview. Int J Gynecol Pathol. 2008;27:161–74.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA

    Robert A. Soslow M.D.

  2. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Deborah F. DeLair M.D.

Authors
  1. Robert A. Soslow M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deborah F. DeLair M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Pathology, Memorial Sloan-Kettering Cancer Center, York Ave. 1275, NEW YORK, 10021, New York, USA

    Robert A. Soslow

  2. SUNY Stony Brook, Department of Pathology, Stony Brook Univ Medical Center, Hospital Level 2, Room 766, Stony Brook, 11794-7025, New York, USA

    Carmen Tornos

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Soslow, R.A., DeLair, D.F. (2011). Pathology of Clear Cell Tumors. In: Soslow, R., Tornos, C. (eds) Diagnostic Pathology of Ovarian Tumors. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9751-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9751-7_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9750-0

  • Online ISBN: 978-1-4419-9751-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation